Key Points
- Lemonade reports Q1 earnings on April 29, before the bell
- Wall Street expects revenue of $254.03 million, up 68% year on year
- EPS loss of $0.58 per share expected, an improvement of 32.6% year on year
- Morgan Stanley upgraded LMND to Buy with an $85 price target, citing autonomous vehicle insurance potential
- Options traders are pricing in a ~14.66% move in either direction on results
Lemonade shares have struggled through the early months of 2026. The insurance technology company has seen its stock decline approximately 8% since January, pressured by inflation worries, volatility in property markets, and ongoing debates about future growth potential. Wednesday’s first quarter earnings release may shift that narrative.
Analysts have set the revenue bar at $254.03 million for the first quarter, representing a 68% increase compared to the prior year period. This projection signals meaningful acceleration from the 53% growth rate Lemonade delivered during the fourth quarter of 2025.
The consensus EPS forecast points to a loss of $0.58 per share. While the company continues to operate at a loss, this figure represents a 32.6% improvement from the same quarter a year earlier. The trend toward narrowing losses remains a central element of the investment thesis.
Options activity around the earnings event suggests significant anticipated volatility. Market participants are building positions that reflect an expected price swing of approximately 14.66% in either direction after results are released. This wide range indicates considerable uncertainty among traders.
The company has established a pattern of exceeding analyst projections. Recent quarterly reports have shown Lemonade surpassing consensus estimates on both revenue and earnings per share, demonstrating an ability to outperform Street expectations.
Heading into this quarterly report, the company’s in-force premium reached $1.24 billion at the close of Q4, reflecting 31% growth year over year. This metric marked the ninth consecutive quarter of accelerating growth, providing support for the bullish investment narrative.
Customer acquisition metrics also present a favorable picture. Throughout 2025, Lemonade brought in approximately 550,000 new customers — representing a 35% increase versus the prior year. Expansion occurred across multiple insurance categories including pet, auto, and homeowners coverage, indicating diversified product demand.
Tesla Partnership Takes Center Stage
Attention surrounding this earnings release centers partly on Lemonade’s insurance offering for Tesla Full Self-Driving customers. The company has committed to reducing per-mile insurance costs by approximately 50% for FSD users, establishing an early foothold in the emerging autonomous vehicle insurance market.
Morgan Stanley analyst Bob Huang recently shifted his stance on LMND from Hold to Buy, simultaneously increasing his price target from $80 to $85. The upgrade emphasized Lemonade’s first-mover positioning in autonomous vehicle insurance as a significant competitive advantage for the coming years.
Analyst Focus Areas for This Report
Beyond headline revenue and earnings figures, market observers will scrutinize updates regarding bad debt patterns and interest expense — both factors that created headwinds in the previous quarter. Rising interest rate concerns connected to geopolitical tensions, particularly the ongoing Iran situation, add another dimension to the analysis.
Comparable companies in the property and casualty insurance sector have already delivered their quarterly results. Stewart Information Services exceeded estimates by 4.7% and saw its shares climb 3.9%. First American Financial topped projections by 2.4% and gained 3.5%. The broader insurance sector has advanced 6.7% during the past month.
Lemonade has outperformed that sector average, rising 12.3% over the same timeframe, though the stock remains down for the full year.
Analyst consensus on LMND currently stands at Hold — comprised of two Buy ratings, four Hold ratings, and two Sell ratings. The average price target among analysts is $54.40, suggesting potential downside from the current trading price of $65.95. Morgan Stanley’s $85 target represents the most optimistic Street view.
Lemonade releases results before market open on April 29.
